在初级保健机构中对痴呆风险查工具的系统审查
Diana Matovic1, Xiaojing Lei1, Gabrielle Picard1
1Macquarie University Lifespan Health & Wellbeing Research Centre, Macquarie University, Sydney, Australia.
American journal of preventive medicine
|September 22, 2025
概括
这次审查发现,心血管风险因素,衰老和痴呆症 (CAIDE) 和大脑健康生活方式 (LBH) 工具对于查中年和老年人痴呆症风险是有效的. 对老年人和低收入国家需要进一步的研究.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 神经学 神经学
背景情况:
- 在初级保健中对痴呆症风险查对于早期干预至关重要.
- 现有的选方法需要对可靠性,有效性,可接受性和可行性进行评估.
- 为了满足这些需求,进行了系统审查.
研究的目的:
- 对初级保健机构的痴呆风险查方法进行系统的审查和分析.
- 评估已识别的选工具的可靠性,有效性,可接受性和可行性.
- 为临床实践和未来研究提供建议.
主要方法:
- 从数据库创建到2024年9月出版的全文,同行评审的英语文章的系统审查.
- 在PubMed,MEDLINE,EMBASE,PsycINFO和COCHRANE中进行的搜索,以向后的雪球.
- 使用已知的工具评估偏差风险 (纽卡斯尔-太华,科克莱恩RoB V2,CASP).
主要成果:
- 在34项具有大量参与者的研究中,评估了11个经过验证的工具/分数.
- 大多数研究来自高收入国家;偏差风险一般较低.
- 心血管风险因素,衰老和痴呆症 (CAIDE) 和大脑健康生活方式 (LBH) 工具在中年和年轻的老年人 (<80岁) 中显示出可接受的有效性.
结论:
- 建议使用CAIDE和LBH工具在初级保健中对80岁以下的成年人进行痴呆风险查.
- 对于80岁及以上的成年人,需要进一步验证.
- 需要进行研究来评估低中等收入国家查工具的性能.
更多相关视频
相关概念视频
Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


